A new method for delivering biomolecules directly into cells
Guided Intracellular Delivery using Precise Area Introduction and Transfection (PAINT)
['FUNDING_R01'] · GEORGIA INSTITUTE OF TECHNOLOGY · NIH-10938834
This study is testing a new method called PAINT that helps deliver important molecules like DNA or proteins directly into specific cells, which could lead to better treatments for patients needing precise cellular therapies.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGIA INSTITUTE OF TECHNOLOGY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10938834 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a technique called PAINT (Precise Area Introduction and Transfection) that allows for the targeted delivery of biomolecules into specific cells. By using a specialized device, researchers aim to precisely control how and where these biomolecules, such as DNA or proteins, are introduced into cells. This method seeks to overcome the limitations of current delivery techniques, which often lack precision and versatility. Patients may benefit from advancements in therapies that rely on effective cellular modification.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions that could benefit from targeted cellular therapies, such as genetic disorders or cancers.
Not a fit: Patients who do not have conditions requiring cellular modification or those who are not candidates for biomolecule therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for various diseases by improving how therapies are delivered at the cellular level.
How similar studies have performed: While the approach of precise biomolecule delivery is innovative, similar techniques have shown promise in preliminary studies, indicating potential for success.
Where this research is happening
ATLANTA, UNITED STATES
- GEORGIA INSTITUTE OF TECHNOLOGY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FEDOROV, ANDREI G — GEORGIA INSTITUTE OF TECHNOLOGY
- Study coordinator: FEDOROV, ANDREI G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.